No Vacillation on HPV Vaccination.
Full text not available from this repository.Item Type: | Article |
---|---|
Status: | Published |
Official URL: | https://doi.org/10.1016/j.cell.2018.02.045 |
Journal or Publication Title: | Cell |
Volume: | 172 |
Number: | 6 |
Page Range: | pp. 1163-1167 |
Date: | 2018 |
Divisions: | Gene and Stem Cell Therapy |
Depositing User: | General Admin |
Identification Number: | 10.1016/j.cell.2018.02.045 |
ISSN: | 00928674 |
Date Deposited: | 04 Jan 2021 23:11 |
Abstract: | Evidence of the safety and protective benefits of human papillomavirus virus (HPV) vaccines as an anti-cancer measure is overwhelming. However, vaccine uptake varies widely across countries and falls short of levels needed to achieve population immunity. We highlight policy measures that would help ensure greater worldwide coverage and save lives. |
Creators: | Creators Email Sipp, Douglas UNSPECIFIED Frazer, Ian H. UNSPECIFIED Rasko, John E.J. UNSPECIFIED |
Last Modified: | 04 Jan 2021 23:11 |
URI: | https://eprints.centenary.org.au/id/eprint/587 |
Actions (login required)
![]() |
View Item |